17-50346373-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_022167.4(XYLT2):c.135+98G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0269 in 984,526 control chromosomes in the GnomAD database, including 1,436 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.071 ( 930 hom., cov: 32)
Exomes 𝑓: 0.019 ( 506 hom. )
Consequence
XYLT2
NM_022167.4 intron
NM_022167.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.16
Genes affected
XYLT2 (HGNC:15517): (xylosyltransferase 2) The protein encoded by this gene is an isoform of xylosyltransferase, which belongs to a family of glycosyltransferases. This enzyme transfers xylose from UDP-xylose to specific serine residues of the core protein and initiates the biosynthesis of glycosaminoglycan chains in proteoglycans including chondroitin sulfate, heparan sulfate, heparin and dermatan sulfate. The enzyme activity, which is increased in scleroderma patients, is a diagnostic marker for the determination of sclerotic activity in systemic sclerosis. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 17-50346373-G-C is Benign according to our data. Variant chr17-50346373-G-C is described in ClinVar as [Benign]. Clinvar id is 1251286.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.199 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XYLT2 | NM_022167.4 | c.135+98G>C | intron_variant | ENST00000017003.7 | NP_071450.2 | |||
XYLT2 | NR_110010.2 | n.150+98G>C | intron_variant | |||||
XYLT2 | XM_005257572.5 | c.-523G>C | upstream_gene_variant | XP_005257629.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XYLT2 | ENST00000017003.7 | c.135+98G>C | intron_variant | 1 | NM_022167.4 | ENSP00000017003.2 | ||||
XYLT2 | ENST00000376550.7 | n.135+98G>C | intron_variant | 1 | ENSP00000365733.3 | |||||
XYLT2 | ENST00000507602.5 | c.135+98G>C | intron_variant | 2 | ENSP00000426501.1 | |||||
XYLT2 | ENST00000509778.1 | c.90+143G>C | intron_variant | 3 | ENSP00000425511.1 |
Frequencies
GnomAD3 genomes AF: 0.0708 AC: 10639AN: 150238Hom.: 930 Cov.: 32
GnomAD3 genomes
AF:
AC:
10639
AN:
150238
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0190 AC: 15809AN: 834180Hom.: 506 AF XY: 0.0187 AC XY: 7227AN XY: 385940
GnomAD4 exome
AF:
AC:
15809
AN:
834180
Hom.:
AF XY:
AC XY:
7227
AN XY:
385940
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0709 AC: 10653AN: 150346Hom.: 930 Cov.: 32 AF XY: 0.0691 AC XY: 5074AN XY: 73464
GnomAD4 genome
AF:
AC:
10653
AN:
150346
Hom.:
Cov.:
32
AF XY:
AC XY:
5074
AN XY:
73464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
69
AN:
3462
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 19, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at